Related Experiment Videos
Antifungal peptides: Origin, activity, and therapeutic potential
1Southern Regional Research Center, USDA, ARS, New Orleans, LA, USA. adelucca@commserver.srrc.usda.gov
Revista Iberoamericana De Micologia
|March 15, 2005
Summary
Antifungal peptides from nature and synthetic versions show promise for fighting fungal infections. Some are now in clinical trials for treating these challenging diseases.
Area of Science:
- Biochemistry
- Microbiology
- Pharmacology
Background:
- Antifungal peptides are found across diverse organisms, including plants, mammals, and microbes.
- These peptides exhibit a wide array of structures and corresponding antifungal activities.
- Natural antifungal peptides serve as templates for developing novel therapeutic agents.
Purpose of the Study:
- To explore the potential of natural and synthetic antifungal peptides in combating fungal infections.
- To highlight the development of superior semisynthetic and fully synthetic analogs from natural peptide precursors.
- To review the progress of promising antifungal peptides that have advanced to clinical trials.
Main Methods:
- Identification and characterization of natural antifungal peptides from various biological sources.
- Design and synthesis of semisynthetic and fully synthetic peptide analogs.
- Evaluation of the antifungal efficacy and properties of natural and synthetic peptides.
- Monitoring the progression of selected antifungal peptides through clinical trials.
Main Results:
- A diverse range of antifungal peptides with varied structures and properties has been identified.
- Synthetic analogs have been developed that demonstrate enhanced antifungal activity compared to their natural counterparts.
- Several promising antifungal peptides are currently undergoing clinical evaluation for human use.
Conclusions:
- Antifungal peptides represent a significant class of compounds with therapeutic potential against fungal infections.
- Synthetic modifications can yield peptide analogs with improved antifungal efficacy.
- The advancement of these peptides into clinical trials underscores their therapeutic promise and the ongoing efforts to combat fungal diseases.